Leveraging transcriptomic, DNA methylation, and molecular alteration data to optimize the classification of IDH-mutant gliomas for therapy selection.

PMCID

PMC12832466

Frontiers in oncology

Authors	Nicolas Castro
Keywords	DNA methylation IDH inhibitors IDH-mutant and 1p/19q co-deleted IDH-mutant astrocytoma IDH-mutant gliomas WHO classification of central nervous system tumors oligodendroglioma single-cell transcriptomic analysis
Year of Publication	2025
Journal	Frontiers in oncology
Volume	15
Pages	1674987
Date Published	12/2025
ISSN	2234-943X
DOI	10.3389/fonc.2025.1674987
PubMed ID	41602379
Links

Recent ӳ��ý Publications